New hope for leukemia patients who have run out of options
NCT ID NCT06052813
Summary
This study is testing a new oral drug called BN104 for adults and adolescents with acute leukemia that has returned or not responded to standard treatments. The main goals are to find a safe dose and see if the drug can help control the cancer. The trial is specifically for patients whose leukemia has certain genetic changes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALL, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Soochow University
Suzhou, 215006, China
Conditions
Explore the condition pages connected to this study.